IL118573A - Pharmaceutical compositions for minimizing bone loss - Google Patents

Pharmaceutical compositions for minimizing bone loss

Info

Publication number
IL118573A
IL118573A IL11857396A IL11857396A IL118573A IL 118573 A IL118573 A IL 118573A IL 11857396 A IL11857396 A IL 11857396A IL 11857396 A IL11857396 A IL 11857396A IL 118573 A IL118573 A IL 118573A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
bone loss
minimizing bone
minimizing
loss
Prior art date
Application number
IL11857396A
Other languages
English (en)
Other versions
IL118573A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL118573A0 publication Critical patent/IL118573A0/xx
Publication of IL118573A publication Critical patent/IL118573A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL11857396A 1995-06-06 1996-06-05 Pharmaceutical compositions for minimizing bone loss IL118573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47111195A 1995-06-06 1995-06-06

Publications (2)

Publication Number Publication Date
IL118573A0 IL118573A0 (en) 1996-10-16
IL118573A true IL118573A (en) 2000-01-31

Family

ID=23870302

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11857396A IL118573A (en) 1995-06-06 1996-06-05 Pharmaceutical compositions for minimizing bone loss

Country Status (27)

Country Link
EP (1) EP0747056B1 (xx)
JP (1) JP2001501907A (xx)
KR (1) KR19990022497A (xx)
CN (1) CN1239429A (xx)
AR (2) AR003002A1 (xx)
AT (1) ATE187643T1 (xx)
AU (1) AU696927B2 (xx)
BR (1) BR9608390A (xx)
CA (1) CA2223174A1 (xx)
CO (1) CO4700447A1 (xx)
CZ (1) CZ383097A3 (xx)
DE (1) DE69605600T2 (xx)
DK (1) DK0747056T3 (xx)
EA (1) EA199800014A1 (xx)
ES (1) ES2142545T3 (xx)
GR (1) GR3032863T3 (xx)
HU (1) HUP9900854A3 (xx)
IL (1) IL118573A (xx)
NO (1) NO975560L (xx)
PE (1) PE2298A1 (xx)
PL (1) PL323941A1 (xx)
PT (1) PT747056E (xx)
SI (1) SI0747056T1 (xx)
TR (1) TR199701508T1 (xx)
WO (1) WO1996039141A1 (xx)
YU (1) YU34296A (xx)
ZA (1) ZA964681B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023740A1 (en) * 1996-11-22 1998-06-04 Akzo Nobel N.V. Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
US5393785A (en) * 1988-10-31 1995-02-28 Endorecherche, Inc. Therapeutic antiestrogens
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
DE4329344A1 (de) * 1993-08-27 1995-03-02 Schering Ag Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri

Also Published As

Publication number Publication date
PE2298A1 (es) 1998-02-28
ATE187643T1 (de) 2000-01-15
DE69605600D1 (de) 2000-01-20
ZA964681B (en) 1997-12-05
CO4700447A1 (es) 1998-12-29
AR003002A1 (es) 1998-05-27
YU34296A (en) 1999-11-22
TR199701508T1 (xx) 1998-03-21
IL118573A0 (en) 1996-10-16
BR9608390A (pt) 1999-05-04
NO975560L (no) 1998-01-26
KR19990022497A (ko) 1999-03-25
ES2142545T3 (es) 2000-04-16
NO975560D0 (no) 1997-12-02
CZ383097A3 (cs) 1998-09-16
AU5981696A (en) 1996-12-24
AU696927B2 (en) 1998-09-24
CN1239429A (zh) 1999-12-22
DE69605600T2 (de) 2000-05-31
CA2223174A1 (en) 1996-12-12
HUP9900854A2 (hu) 1999-08-30
EA199800014A1 (ru) 1998-06-25
EP0747056B1 (en) 1999-12-15
HUP9900854A3 (en) 2000-03-28
JP2001501907A (ja) 2001-02-13
EP0747056A3 (en) 1997-03-05
PL323941A1 (en) 1998-04-27
EP0747056A2 (en) 1996-12-11
SI0747056T1 (en) 2000-06-30
GR3032863T3 (en) 2000-07-31
AR003134A1 (es) 1998-07-08
WO1996039141A1 (en) 1996-12-12
PT747056E (pt) 2000-05-31
DK0747056T3 (da) 2000-05-01

Similar Documents

Publication Publication Date Title
ZA957247B (en) Pharmaceutical compositions
HUP9802086A3 (en) Pharmaceutical composition for piperidinoalkanol compounds
ZA967827B (en) Pharmaceutical compositions
IL118590A (en) Pharmaceutical composition for minimizing bone loss
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
EG24294A (en) Pharmaceutical compositions
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
ZA954469B (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
IL118573A (en) Pharmaceutical compositions for minimizing bone loss
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
HUP0003528A3 (en) Pharmaceutical compositions containing dihydropolyprenols
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
HK1087642A1 (en) Sterile pharmaceutical composition
GB9707483D0 (en) Pharmaceutical compositions
GB9505164D0 (en) Pharmaceutical compositions
HU0500763D0 (en) Pharmaceutical compositions
GB9519157D0 (en) Pharmaceutical compositions
GB9517133D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees